US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

PMGC Holdings Inc. - Common Stock (NQ:ELAB)

3.360 +0.140 (+4.35%)
Delayed Quote Updated: 3:32 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PMGC Holdings Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Top 4 Defensive Stocks That Could Lead To Your Biggest Gains In January ↗
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket ↗
Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market... 
Via Benzinga
News headline image
ELAB Stock Earnings: Elevai Labs Reported Results for Q3 2024 ↗
Elevai Labs just reported results for the third quarter of 2024. 
Via InvestorPlace
News headline image
Why Is Elevai Labs (ELAB) Stock Up Today? ↗
Elevai Labs is soaring on an intriguing licensing agreement with INmune Bio, but the narrative presents a mixed bag for ELAB stock. 
Via InvestorPlace
News headline image
Why Elevai Labs Stock Is Trading Higher ↗
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune... 
Via Benzinga
News headline image
Dow Dips 200 Points; Goldman Sachs Earnings Top Views ↗
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ... 
Via Benzinga
Topics Stocks
News headline image
ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
ELEVAI Labs to commercialize use of proprietary technology designed to produce high-quality, cGMP grade mesenchymal stromal cells at lower-cost 
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
12 Consumer Staples Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to... 
Via Benzinga
News headline image
Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
Company Records Record Quarterly Revenues 
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
ELEVAI Labs, Inc. Expands International Distribution into Europe
From Elevai Labs Inc.
Via GlobeNewswire
News headline image
Fenbo Holdings Debuts In Another Slow Week For IPOs ↗
Fenbo Holdings made its trading debut on Thursday in another slow IPO week in the US. Entering the last month of 2023, the outlook for 2024 market debuts looks better, as it would be difficult to be... 
Via Talk Markets
Topics Initial Public Offering
News headline image
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. 
Via Benzinga
News headline image
Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products
From Elevai Labs Inc.
Via GlobeNewswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >